Evidence map›Paper›PMID 34210734›Full record

ArticleBMJ open2021

The Magnetic Couples Study: protocol for a mixed methods prospective cohort study of HIV-serodifferent heterosexual couples' perspectives and use of pre-exposure prophylaxis (PrEP).

James M McMahon, Janie Simmons, Jessica E Haberer, Sharon Mannheimer, Natalie M Leblanc, Leilani Torres, Robert Quiles, Guillermo Aedo, Anabel Javier, Amy Braksmajer and 8 more

Abstract read
In one paragraph

Article in BMJ open, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

James M McMahonSchool of Nursing, University of Rochester Medical Center, Rochester, New York, USA james_mcmahon@urmc.rochester.edu.ORCID 0000-0003-4707-5141
Janie SimmonsSchool of Global Public Health, New York University, New York, New York, USA.ORCID 0000-0002-0320-9139
Jessica E HabererCenter for Global Health, Massachusetts General Hospital, Boston, Massachusetts, USA.
Sharon MannheimerDepartment of Medicine, New York City Health + Hospitals Harlem, New York, New York, USA.
Natalie M LeblancSchool of Nursing, University of Rochester Medical Center, Rochester, New York, USA.
Leilani TorresSchool of Nursing, University of Rochester Medical Center, Rochester, New York, USA.
Robert QuilesSchool of Nursing, University of Rochester Medical Center, Rochester, New York, USA.
Guillermo AedoSchool of Global Public Health, New York University, New York, New York, USA.
Anabel JavierSchool of Global Public Health, New York University, New York, New York, USA.
Amy BraksmajerDepartment of Sociology, State University of New York at Geneseo, Geneseo, New York, USA.
Graham HarrimanHIV Health and Human Services Planning Council, New York City Department of Health and Mental Hygiene, Queens, New York, USA.
Nicole TraboldCollege of Health Science and Technology, Rochester Institute of Technology, Rochester, New York, USA.
Enrique R PougetDepartment of Health and Nutrition Sciences, Brooklyn College, The City University of New York, Brooklyn, New York, USA.
Ann KurthSchool of Nursing, Yale University, Orange, Connecticut, USA.
Martez D R SmithSchool of Nursing, University of Rochester Medical Center, Rochester, New York, USA.
Judith BraschSchool of Nursing, University of Rochester Medical Center, Rochester, New York, USA.
Eric J PodsiadlySchool of Nursing, University of Rochester Medical Center, Rochester, New York, USA.
Peter L AndersonSchool of Pharmacy and Pharmaceutical Sciences, University of Colorado - Anschutz Medical Campus, Aurora, Colorado, USA.

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
PrEP implementation with US HIV-serodiscordant couples: Couples PrEP Demo ProjectR01MH107371 · NIMH · UNIVERSITY OF ROCHESTER · PI MCMAHON, JAMES M · 2015 to 2019
$3.4M
Formative research on PrEP provision in U.S. HIV-serodiscordant couplesR56MH103047 · NIMH · UNIVERSITY OF ROCHESTER · PI MCMAHON, JAMES M · 2014 to 2014
$445k
NCATS NIH HHS UL1 TR001863NIMH NIH HHS R01 MH107371NIMH NIH HHS R56 MH103047
6 · The paper itself

Abstract

introductionHIV transmission within serodifferent heterosexual couples plays a key role in sustaining the global HIV pandemic. In the USA, transmission within established mixed-status couples accounts for up to half of all new HIV infections among heterosexuals. Oral HIV pre-exposure prophylaxis (PrEP) is a highly effective prevention method, although underutilised among serodifferent couples. Moreover, there is a dearth of research on US HIV-serodifferent couples' perspectives and use of PrEP, alone or in combination with other prevention methods. In this paper, we describe the study protocol for the Magnetic Couples Study, designed to fill critical knowledge gaps regarding HIV-serodifferent heterosexual couples' perspectives, experiences and utilisation of PrEP. METHODS AND ANALYSIS: The Magnetic Couples Study is a mixed methods prospective cohort study designed to describe temporal patterns and identify determinants at multiple levels (individual, couple, HCF) of PrEP outcomes along the care continuum (PrEP awareness, linkage, uptake, retention and medication adherence) among HIV-serodifferent heterosexual couples residing in New York City. The study will also examine clinical management of PrEP, side effects and changes in sexual-related and substance use-related behaviour. A prospective cohort of 230 mixed-status couples already on oral PrEP was recruited, with quarterly assessments over 18 months; in addition, a cross-sectional sample of 150 mixed-status couples not currently on PrEP was recruited. In-depth semistructured qualitative interviews were conducted with a subsample of 25 couples. Actor-partner interdependence modelling using multilevel analysis will be employed for the analysis of longitudinal dyadic data. Framework analysis will be used to analyse qualitative data. A parallel convergent design will be used for mixed methods integration. ETHICS AND DISSEMINATION: The study was approved by the University of Rochester Institutional Review Board (RSRB00052766). Study findings will be disseminated to community members and providers and to researchers and policy makers.

Indexed as

Anti-HIV AgentsHIV InfectionsPre-Exposure ProphylaxisCross-Sectional StudiesFamily CharacteristicsHeterosexualityHumansMagnetic PhenomenaNew York CityProspective StudiesSexual PartnersAnti-HIV AgentsepidemiologyHIV & AIDSpreventive medicine

Identifiers

PMID34210734
PMCPMC8252879

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.